BRAINSTORM CELL THERAPEUTICS INC. Payments for Repurchase of Warrants
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BRAINSTORM CELL THERAPEUTICS INC. payments for repurchase of warrants for the quarter ending 2016-09-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. payments for repurchase of warrants for the quarter ending 2016-06-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. payments for repurchase of warrants for the quarter ending 2015-12-31 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. payments for repurchase of warrants for the quarter ending 2015-09-30 was $0.00.
- BRAINSTORM CELL THERAPEUTICS INC. payments for repurchase of warrants for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- BRAINSTORM CELL THERAPEUTICS INC. payments for repurchase of warrants for fiscal 2014 was $600.00K.
- BRAINSTORM CELL THERAPEUTICS INC. payments for repurchase of warrants for fiscal 2013 was $0.00.
| Period end | Payments for Repurchase of Warrants 3 month | Payments for Repurchase of Warrants 12 month |
|---|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-11 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $0.00 10-K · filed 2016-03-09 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | -$12.40M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-11 | -$12.40M derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$12.40M 10-Q · filed 2015-05-14 | -$11.80M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $600.00K 10-K · filed 2016-03-09 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-16 | $600.00K derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | $600.00K 10-Q · filed 2015-08-13 | $600.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $0.00 derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $0.00 10-K · filed 2015-03-26 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |